FIDOQUEL Trademark

Trademark Overview

On Friday, October 29, 2021, a trademark application was filed for FIDOQUEL with the United States Patent and Trademark Office. The USPTO has given the FIDOQUEL trademark a serial number of 97099935. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Monday, July 14, 2025. This trademark is owned by Genus Lifesciences, Inc.. The FIDOQUEL trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical preparations for the prevention of epilepsy; Pharmaceutical and veterinary substances, preparations and formulations for the prevention and treatment of epilepsy; Chemical reagents for medical or veterinary purposes

General Information

Serial Number97099935
Word MarkFIDOQUEL
Filing DateFriday, October 29, 2021
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateMonday, July 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesVeterinary pharmaceutical preparations for the prevention of epilepsy; Pharmaceutical and veterinary substances, preparations and formulations for the prevention and treatment of epilepsy; Chemical reagents for medical or veterinary purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code005
First Use Anywhere DateFriday, March 21, 2025
First Use In Commerce DateFriday, March 21, 2025

Trademark Owner History

Party NameGenus Lifesciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllentown, PA 18109
Party NameGenus Lifesciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllentown, PA 18109

Trademark Events

Event DateEvent Description
Wednesday, August 10, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 2, 2021NEW APPLICATION ENTERED
Thursday, November 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 8, 2022ASSIGNED TO EXAMINER
Wednesday, August 10, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 2, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 2, 2023SOU EXTENSION 1 FILED
Monday, October 2, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Friday, October 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 3 GRANTED
Friday, October 4, 2024SOU EXTENSION 3 FILED
Wednesday, April 2, 2025USE AMENDMENT FILED
Wednesday, April 2, 2025TEAS STATEMENT OF USE RECEIVED
Monday, July 14, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, July 14, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 14, 2025NON-FINAL ACTION E-MAILED
Monday, July 14, 2025SU - NON-FINAL ACTION - WRITTEN
Monday, July 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

fidoquel veterinary epilepsy prevention preparations pharmaceutical medical purposes reagents substances formulations